Oracle Alpha Inc. Roivant Sciences Ltd. Call Options Transaction History
Oracle Alpha Inc.
- $55.7 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ROIV
# of Institutions
315Shares Held
496MCall Options Held
991KPut Options Held
1.15M-
Sb Investment Advisers (Uk) LTD London, X071.4MShares$824 Million6.97% of portfolio
-
Viking Global Investors LP69.2MShares$799 Million2.91% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$771 Million72.99% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$409 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.3MShares$339 Million0.02% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.14B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...